An anticancer therapy-elicited immunosurveillance system that eliminates tetraploid cells

Laura Senovilla, Ilio Vitale, Isabelle Martins, Oliver Kepp, Lorenzo Galluzzi, Laurence Zitvoge, Maria Castedo, Guido Kroemer

    Research output: Contribution to journalArticlepeer-review

    22 Citations (Scopus)

    Abstract

    One of the driving forces of oncogenesis is tetraploidy, a duplication of the DNA content that, upon asymmetric cell division or progressive chromosome loss, can originate aneuploidy. Recent findings from our group indicate the existence of an immunosurveillance system that eliminates tetraploid cancer cells. We surmise that tetraploidy-inducing chemotherapeutic agents may elicit potent anticancer responses by re-activating this immunosurveillance system.

    Original languageEnglish
    Article numbere22409
    JournalOncoImmunology
    Volume2
    Issue number1
    DOIs
    Publication statusPublished - 1 Jan 2013

    Keywords

    • Breast carcinoma
    • Calreticulin
    • HMGB1
    • Hyperploidy
    • Immunogenic cell death
    • Mitotic catastrophe

    Cite this